Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,649 | 132 | 96.5% |
| Education | $94.99 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $637.56 | 36 | $0 (2024) |
| Galderma Laboratories, L.P. | $245.80 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $190.36 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $170.87 | 5 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $150.91 | 7 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $150.05 | 4 | $0 (2024) |
| UCB, Inc. | $136.95 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $128.64 | 7 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $114.60 | 5 | $0 (2024) |
| Amgen Inc. | $105.35 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,577 | 76 | ABBVIE INC. ($263.92) |
| 2023 | $277.22 | 10 | Janssen Biotech, Inc. ($94.99) |
| 2022 | $292.83 | 15 | Novartis Pharmaceuticals Corporation ($78.24) |
| 2021 | $80.88 | 5 | AbbVie Inc. ($35.74) |
| 2020 | $70.76 | 4 | AbbVie Inc. ($52.33) |
| 2019 | $433.38 | 22 | AbbVie, Inc. ($174.89) |
| 2018 | $11.09 | 1 | Galderma Laboratories, L.P. ($11.09) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Immunology | ||||||
| 12/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.12 | General |
| Category: Immunology | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/01/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $37.65 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/26/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $62.61 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Immunology | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,775 | 3,513 | $278,355 | $134,144 |
| 2022 | 28 | 1,993 | 3,550 | $304,705 | $147,867 |
| 2021 | 16 | 793 | 1,268 | $105,160 | $60,315 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 363 | $54,450 | $29,296 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 380 | 509 | $50,950 | $29,026 | 57.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 313 | 432 | $38,880 | $16,972 | 43.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 45 | 48 | $19,200 | $11,050 | 57.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 246 | 1,573 | $23,595 | $7,430 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 92 | 92 | $13,850 | $6,199 | 44.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 27 | 40 | $7,700 | $3,688 | 47.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 37 | $12,025 | $3,487 | 29.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 46 | 47 | $7,050 | $3,479 | 49.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 72 | $5,400 | $2,723 | 50.4% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 11 | 11 | $4,950 | $2,622 | 53.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 20 | 21 | $7,350 | $2,385 | 32.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 19 | $4,750 | $2,331 | 49.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $3,825 | $2,228 | 58.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 26 | 26 | $3,900 | $2,186 | 56.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 27 | 29 | $5,075 | $1,881 | 37.1% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 13 | $2,925 | $1,556 | 53.2% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 15 | $2,625 | $1,512 | 57.6% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 16 | 17 | $2,550 | $1,392 | 54.6% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 13 | 13 | $2,400 | $978.24 | 40.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 23 | $1,725 | $638.96 | 37.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,560 | $614.46 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 28 | $840.00 | $260.64 | 31.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 19 | 23 | $460.00 | $187.28 | 40.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 32 | $320.00 | $23.93 | 7.5% |
About Abby Vrable
Abby Vrable is a Dermatology healthcare provider based in Fairlawn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1285098491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abby Vrable has received a total of $2,744 in payments from pharmaceutical and medical device companies, with $1,577 received in 2024. These payments were reported across 133 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,649).
As a Medicare-enrolled provider, Vrable has provided services to 4,561 Medicare beneficiaries, totaling 8,331 services with total Medicare billing of $342,326. Data is available for 3 years (2021–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Fairlawn, OH
- Active Since 04/13/2016
- Last Updated 07/11/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1285098491
Products in Payments
- SKYRIZI (Biological) $235.36
- Otezla (Drug) $174.92
- RINVOQ (Biological) $174.87
- DUPIXENT (Biological) $174.03
- TREMFYA (Drug) $170.87
- DAXXIFY (Drug) $150.05
- Bimzelx (Biological) $136.95
- Humira (Biological) $126.08
- COSENTYX (Biological) $105.63
- ILUMYA (Biological) $103.99
- Sotyktu (Drug) $92.48
- COSENTYX (Drug) $84.73
- OPZELURA (Drug) $69.44
- Cabtreo (Drug) $67.46
- SPEVIGO (Drug) $60.89
- TALTZ (Drug) $57.01
- LIBTAYO (Biological) $54.59
- HUMIRA (Biological) $52.44
- Skyrizi (Biological) $48.81
- Winlevi (Drug) $46.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fairlawn
James Libecco, Md, MD
Dermatology — Payments: $1.2M
Ann Kooken, M.d, M.D
Dermatology — Payments: $15,764
Dr. Angela Funovits, M.d, M.D
Dermatology — Payments: $13,396
Valerie Fuller, D.o, D.O
Dermatology — Payments: $12,672
Dr. Kimberly Tamargo, Md, MD
Dermatology — Payments: $8,950
Dr. Allison Moosally, Md, MD
Dermatology — Payments: $6,093